From: Radiotherapeutic alternatives for previously irradiated recurrent gliomas
Author | Pt. Number | Histology | Median Dose (Gy) | Tumor size (ml; median) | Median survival (months) | Rate of Severe Toxiticy/Reoperation rate (%) |
---|---|---|---|---|---|---|
Chamberlain et al, 1994 | 20 | 5 GBM, 10 AA, 5 other | 13.4 | 17 | 8 | - |
Cho et al., 1999 | 46 | 27 GBM/19 AA | 17 | 10 | 11 | 22% |
Combs et al., 2005 | 32 | GBM | 15 | 10 | 10 | - |
Hall et al., 1995 | 35 | 26 GBM, 9 AA | 20 | 28 | 8 | 31% |
Kondziolka et al., 1997 | 23 | AA | 15.6 | 6 | 31 | 23% |
Kondziolka et al., 1997 | 19 | GBM | 15 | 6.5 | 30 | 19% |
Shrieve et al., 1995 | 86 | GBM | 13 | 10.1 | 10.2 | 22% |